D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
EHC holding history
Encompass Health Corp in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EHC overviewAll 13F holders of EHCFull Q2 2026 holdings
- Shares (Q2 2026)
- 384,595
- Value
- $38.9M
- % of portfolio
- <0.1%
- Quarters held
- 18
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 384,595 | $38.9M | <0.1% | −180,760−32.0% | Reduced | Holders |
| Q1 2026 | 565,355 | $54.7M | <0.1% | +227,029+67.1% | Added | Holders |
| Q4 2025 | 338,326 | $35.9M | <0.1% | +275,610+439.5% | Added | Holders |
| Q3 2025 | 62,716 | $7.97M | <0.1% | −97,671−60.9% | Reduced | Holders |
| Q2 2025 | 160,387 | $19.7M | <0.1% | +103,391+181.4% | Added | Holders |
| Q1 2025 | 56,996 | $5.77M | <0.1% | −5,998−9.5% | Reduced | Holders |
| Q4 2024 | 62,994 | $5.82M | <0.1% | +48,517+335.1% | Added | Holders |
| Q3 2024 | 14,477 | $1.40M | <0.1% | +14,477 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −27,032−100.0% | Sold out | Holders |
| Q1 2024 | 27,032 | $2.23M | <0.1% | +8,130+43.0% | Added | Holders |
| Q4 2023 | 18,902 | $1.26M | <0.1% | +18,902 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −5,700−100.0% | Sold out | Holders |
| Q2 2023 | 5,700 | $385.9K | <0.1% | −59,525−91.3% | Reduced | Holders |
| Q1 2023 | 65,225 | $3.53M | <0.1% | +65,225 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −112,631−100.0% | Sold out | Holders |
| Q2 2022 | 112,631 | $6.31M | <0.1% | −433,070−79.4% | Reduced | Holders |
| Q1 2022 | 545,701 | $38.8M | 0.1% | −225,756−29.3% | Reduced | Holders |
| Q4 2021 | 771,457 | $50.3M | 0.1% | −21,051−2.7% | Reduced | Holders |
| Q3 2021 | 792,508 | $59.5M | 0.1% | +274,296+52.9% | Added | Holders |
| Q2 2021 | 518,212 | $40.4M | <0.1% | +278,926+116.6% | Added | Holders |
| Q1 2021 | 239,286 | $19.6M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.